Clinical trials · Washington, D.C., DC
Autosomal Dominant Polycystic Kidney Disease clinical trials in Washington, D.C.
We’re tracking 3 recruiting autosomal dominant polycystic kidney disease studies with a site in or near Washington, D.C. — including Phase 1 and Phase 3 studies, each written for real people, not researchers.
Recruiting studies near Washington, D.C.
- NCT04338048Recruiting
Study for autosomal dominant polycystic kidney disease
This study enrolls people who have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic kidney condition that can cause kidney cysts. It aims to learn about this specific form of the disease so better care is possible for the right patients.
Washington D.C., District of ColumbiaAges Up to 18 years - NCT07223502RecruitingPhase 3
Comparing two treatments for high blood pressure and kidney disease
This trial tests if a new treatment combination (finerenone plus a water pill) works better than a standard fixed-dose combination for people with both high blood pressure and chronic kidney disease. It aims to find which option provides more clinical benefit.
Vienna, VirginiaAges 18 years+ - NCT07228364RecruitingPhase 1
Testing safety of AZD1613 for polycystic kidney disease
This trial tests a new study drug called AZD1613 for adults with a certain type of kidney disease (ADPKD). Researchers want to see if it is safe, how the body handles it, and what the right dose might be.
Baltimore, MarylandAges 18–65
Hear when a new Autosomal Dominant Polycystic Kidney Disease trial opens near Washington, D.C., DC
We’ll email you when one opens near Washington, D.C., DC — at most once a week, no account needed, unsubscribe anytime.
Autosomal Dominant Polycystic Kidney Disease trials in other cities
Where these studies are running near Washington, D.C.
Institutions with a site for the recruiting autosomal dominant polycystic kidney disease studies listed above.
- Children's National Medical Center
- Research Site
- Sarfez Pharmaceuticals, Inc.
What taking part in a autosomal dominant polycystic kidney disease study involves
A screening visit first
Before anything else, the study team checks whether you fit — usually a visit with some tests. You can stop at any point, and screening is typically free.
Care at a nearby site
Study visits happen at a clinic or hospital taking part. Many studies cover the cost of the study treatment and related visits, and some reimburse travel.
You stay in control
Taking part is voluntary and you can leave a study at any time, for any reason, without affecting your regular care.
The team decides eligibility
Our fit check is a helpful first read, not a decision. The study team makes the final call after reviewing your health history.
Common questions
- Are there autosomal dominant polycystic kidney disease clinical trials near Washington, D.C.?
- Yes. We're currently tracking 3 recruiting autosomal dominant polycystic kidney disease studies with a site near Washington, D.C., each rewritten in plain language so you can see what it's testing and who it's for.
- How do I find out if I qualify for a autosomal dominant polycystic kidney disease study near Washington, D.C.?
- Each study lists its eligibility rules — age, diagnosis, prior treatments. On every trial page we explain these in plain language and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Do I have to live in Washington, D.C. to take part?
- Not necessarily. These studies have a site near Washington, D.C., but eligibility is about your health, not your address — some people travel to take part, and a few studies reimburse travel. The study team can tell you what's required.
- Does it cost anything to join a autosomal dominant polycystic kidney disease trial?
- Using Clin2 is always free. Many trials cover the study treatment and related visits; some reimburse travel. The study team explains exactly what's covered before you decide.
Not the right time?
New autosomal dominant polycystic kidney disease studies open near Washington, D.C. regularly. Set up a health profile and we’ll quietly watch for studies that fit you and email you when one opens.